BioMarin Pharmaceutical
BMRN
$81.90
Share price
-0.33%
Change (1 day)
-14.30%
Change (1 year)
Categories
Earnings for BioMarin Pharmaceutical (BMRN)
Earnings in 2023 (TTM): $0.18 B
According to BioMarin Pharmaceutical's latest financial reports the company's current earnings (TTM) are $0.18 B. In 2022 the company made an earning of $0.14 B an increase over its 2021 earnings that were of -$75.35 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for BioMarin Pharmaceutical from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $0.18 B | 26.07% |
| 2022 | $0.14 B | -298.51% |
| 2021 | -$75.35 M | 78.04% |
| 2020 | -$42.33 M | -55.36% |
| 2019 | -$94.82 M | -33.56% |
| 2018 | -$0.15 B | 297.78% |
| 2017 | -$35.88 M | -95.68% |
| 2016 | -$0.84 B | 437.12% |
| 2015 | -$0.16 B | 23.91% |
| 2014 | -$0.13 B | -29.25% |
| 2013 | -$0.18 B | 49.23% |
| 2012 | -$0.12 B | 171.11% |
| 2011 | -$43.63 M | 103.01% |
| 2010 | -$21.49 M | -3903.54% |
| 2009 | $0.56 M | -98.31% |
| 2008 | $33.42 M | -189.7% |
| 2007 | -$37.27 M | 51.02% |
| 2006 | -$24.68 M | -61.58% |
| 2005 | -$64.22 M | -56.59% |
| 2004 | -$0.15 B | 95.13% |
| 2003 | -$75.81 M | 12.09% |
| 2002 | -$67.63 M | 73.19% |
| 2001 | -$39.05 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $8.39 B | 4,352.27% | 🇫🇷 France |
 Ultragenyx RARE | -$0.55 B | -387.68% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | -$0.12 B | -163.10% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -$0.16 B | -179.69% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | -$0.16 B | -179.60% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $94.51 M | -49.88% | 🇺🇸 USA |